157335-92-7 Usage
Description
5-Pyrimidinecarboxylic acid, 4-methyl-, also known as 4-Methyl-5-pyrimidinecarboxylic acid, is an organic compound with the molecular formula C5H4N2O2. It is a derivative of pyrimidine, a heterocyclic aromatic organic compound that is a component of nucleic acids. 5-Pyrimidinecarboxylicacid,4-methylis characterized by the presence of a methyl group at the 4th position and a carboxylic acid functional group at the 5th position of the pyrimidine ring.
Uses
Used in Chemical Synthesis:
5-Pyrimidinecarboxylic acid, 4-methyl-, is used as a reagent in the synthesis of bis(pyrimidin-5-yl)methanes. These compounds are known for their herbicidal activity, making them valuable in the agricultural industry for controlling unwanted weeds in crop fields. The use of 4-Methyl-5-pyrimidinecarboxylic acid in the production of these herbicides helps to improve crop yield and quality by reducing the competition for resources between crops and weeds.
Used in Pharmaceutical Industry:
In addition to its application in agriculture, 5-Pyrimidinecarboxylic acid, 4-methyl-, may also have potential uses in the pharmaceutical industry. Due to its structural similarity to nucleic acids, it could be utilized in the development of new drugs targeting various diseases, including cancer and viral infections. Further research and development are required to explore these potential applications fully.
Check Digit Verification of cas no
The CAS Registry Mumber 157335-92-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,3,3 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 157335-92:
(8*1)+(7*5)+(6*7)+(5*3)+(4*3)+(3*5)+(2*9)+(1*2)=147
147 % 10 = 7
So 157335-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O2/c1-4-5(6(9)10)2-7-3-8-4/h2-3H,1H3,(H,9,10)
157335-92-7Relevant articles and documents
PYRAZOLE DERIVATIVES AS MODULATORS OF CALCIUM RELEASE -ACTIVATED CALCIUM CHANNEL
-
Page/Page column 69-70, (2011/04/26)
Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.
